

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proline metabolic process (GO:0006560) | 8.80648891 |
| 2 | transcription from mitochondrial promoter (GO:0006390) | 7.96329993 |
| 3 | DNA deamination (GO:0045006) | 7.24284731 |
| 4 | replication fork processing (GO:0031297) | 6.95793753 |
| 5 | embryonic process involved in female pregnancy (GO:0060136) | 6.77311202 |
| 6 | positive regulation of protein homooligomerization (GO:0032464) | 6.41953006 |
| 7 | oxidative demethylation (GO:0070989) | 5.80338331 |
| 8 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 5.77535085 |
| 9 | regulation of protein homooligomerization (GO:0032462) | 5.68308430 |
| 10 | poly(A)+ mRNA export from nucleus (GO:0016973) | 5.49233081 |
| 11 | mitochondrial DNA metabolic process (GO:0032042) | 5.38326466 |
| 12 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 5.31266260 |
| 13 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 5.31266260 |
| 14 | establishment of apical/basal cell polarity (GO:0035089) | 5.29021082 |
| 15 | regulation of integrin activation (GO:0033623) | 5.28585916 |
| 16 | glutamine family amino acid biosynthetic process (GO:0009084) | 5.00836512 |
| 17 | DNA strand renaturation (GO:0000733) | 5.00094066 |
| 18 | viral mRNA export from host cell nucleus (GO:0046784) | 4.90897575 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 4.81590511 |
| 20 | mannose metabolic process (GO:0006013) | 4.62804894 |
| 21 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 4.52502777 |
| 22 | establishment of monopolar cell polarity (GO:0061162) | 4.52502777 |
| 23 | mitotic G1 DNA damage checkpoint (GO:0031571) | 4.48035380 |
| 24 | formation of translation preinitiation complex (GO:0001731) | 4.45187020 |
| 25 | GDP-mannose metabolic process (GO:0019673) | 4.40041056 |
| 26 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.34450947 |
| 27 | negative regulation of cell cycle arrest (GO:0071157) | 4.29151928 |
| 28 | mRNA cleavage (GO:0006379) | 4.22244212 |
| 29 | embryonic placenta development (GO:0001892) | 4.07422909 |
| 30 | negative regulation of JAK-STAT cascade (GO:0046426) | 4.06645446 |
| 31 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.05379966 |
| 32 | mitotic G1/S transition checkpoint (GO:0044819) | 4.05231718 |
| 33 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.04552331 |
| 34 | glutathione biosynthetic process (GO:0006750) | 3.99499790 |
| 35 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.90731285 |
| 36 | G1 DNA damage checkpoint (GO:0044783) | 3.89951153 |
| 37 | base-excision repair (GO:0006284) | 3.89822670 |
| 38 | mitochondrial RNA metabolic process (GO:0000959) | 3.86502136 |
| 39 | regulation of translational fidelity (GO:0006450) | 3.84908990 |
| 40 | cellular response to ATP (GO:0071318) | 3.84277779 |
| 41 | DNA integration (GO:0015074) | 3.82623813 |
| 42 | cellular response to zinc ion (GO:0071294) | 3.79024854 |
| 43 | negative regulation of protein oligomerization (GO:0032460) | 3.75827844 |
| 44 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.74305206 |
| 45 | positive regulation of protein oligomerization (GO:0032461) | 3.68233446 |
| 46 | interferon-gamma secretion (GO:0072643) | 3.64509466 |
| 47 | base-excision repair, AP site formation (GO:0006285) | 3.63873205 |
| 48 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.61820382 |
| 49 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.61723662 |
| 50 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.61301512 |
| 51 | positive regulation of developmental pigmentation (GO:0048087) | 3.58697498 |
| 52 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.56819872 |
| 53 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.53204442 |
| 54 | DNA double-strand break processing (GO:0000729) | 3.51754937 |
| 55 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.49544849 |
| 56 | intestinal cholesterol absorption (GO:0030299) | 3.49386024 |
| 57 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.49374076 |
| 58 | regulation of protein oligomerization (GO:0032459) | 3.44162880 |
| 59 | positive regulation by host of viral transcription (GO:0043923) | 3.43923401 |
| 60 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.39446595 |
| 61 | alkaloid metabolic process (GO:0009820) | 3.38516824 |
| 62 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.35549515 |
| 63 | non-recombinational repair (GO:0000726) | 3.35549515 |
| 64 | dosage compensation (GO:0007549) | 3.33739687 |
| 65 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 3.29499530 |
| 66 | NIK/NF-kappaB signaling (GO:0038061) | 3.29075928 |
| 67 | activation of MAPKKK activity (GO:0000185) | 3.27408590 |
| 68 | face development (GO:0060324) | 3.26815946 |
| 69 | negative regulation of mRNA processing (GO:0050686) | 3.26566762 |
| 70 | mitochondrial DNA replication (GO:0006264) | 3.25699556 |
| 71 | termination of RNA polymerase II transcription (GO:0006369) | 3.25055715 |
| 72 | embryonic camera-type eye development (GO:0031076) | 3.21984805 |
| 73 | NADH metabolic process (GO:0006734) | 3.20861037 |
| 74 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.17677346 |
| 75 | negative regulation of Ras GTPase activity (GO:0034261) | 3.16111403 |
| 76 | modulation by virus of host process (GO:0019054) | 3.16031469 |
| 77 | telomere maintenance via recombination (GO:0000722) | 3.15338154 |
| 78 | negative regulation of viral release from host cell (GO:1902187) | 3.14983690 |
| 79 | DNA topological change (GO:0006265) | 3.13621497 |
| 80 | meiotic chromosome segregation (GO:0045132) | 3.11584503 |
| 81 | trophectodermal cell differentiation (GO:0001829) | 3.10876683 |
| 82 | neutrophil activation involved in immune response (GO:0002283) | 3.07500301 |
| 83 | positive regulation of DNA repair (GO:0045739) | 3.06973689 |
| 84 | regulation of ARF GTPase activity (GO:0032312) | 3.06728001 |
| 85 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.06692663 |
| 86 | histone H4-K12 acetylation (GO:0043983) | 3.06192480 |
| 87 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.05987243 |
| 88 | modulation by symbiont of host cellular process (GO:0044068) | 3.03191828 |
| 89 | protein localization to endosome (GO:0036010) | 3.02274839 |
| 90 | convergent extension (GO:0060026) | 3.01832075 |
| 91 | negative regulation of RNA splicing (GO:0033119) | 3.01602597 |
| 92 | response to peptidoglycan (GO:0032494) | 3.00895335 |
| 93 | COPI coating of Golgi vesicle (GO:0048205) | 3.00530559 |
| 94 | Golgi transport vesicle coating (GO:0048200) | 3.00530559 |
| 95 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.99658124 |
| 96 | DNA ligation (GO:0006266) | 2.98246858 |
| 97 | maturation of 5.8S rRNA (GO:0000460) | 2.97719131 |
| 98 | DNA strand elongation (GO:0022616) | 2.97549189 |
| 99 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.96690334 |
| 100 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.89598788 |
| 101 | anatomical structure regression (GO:0060033) | 2.89076533 |
| 102 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.87268514 |
| 103 | positive regulation of circadian rhythm (GO:0042753) | 2.86514261 |
| 104 | urea cycle (GO:0000050) | 2.86112820 |
| 105 | response to muramyl dipeptide (GO:0032495) | 2.86051343 |
| 106 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.85667135 |
| 107 | regulation of DNA damage checkpoint (GO:2000001) | 2.85176813 |
| 108 | regulation of double-strand break repair (GO:2000779) | 2.84511433 |
| 109 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.84332567 |
| 110 | N-glycan processing (GO:0006491) | 2.80116852 |
| 111 | leukotriene metabolic process (GO:0006691) | 2.80021621 |
| 112 | glycosphingolipid catabolic process (GO:0046479) | 2.79488928 |
| 113 | DNA demethylation (GO:0080111) | 2.79308628 |
| 114 | glial cell migration (GO:0008347) | 2.78393579 |
| 115 | apoptotic process involved in morphogenesis (GO:0060561) | 2.78366534 |
| 116 | cullin deneddylation (GO:0010388) | 2.77527709 |
| 117 | kinetochore assembly (GO:0051382) | 2.76958561 |
| 118 | semaphorin-plexin signaling pathway (GO:0071526) | 2.76595673 |
| 119 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.76593794 |
| 120 | resolution of meiotic recombination intermediates (GO:0000712) | 2.76199714 |
| 121 | telomere maintenance via telomere lengthening (GO:0010833) | 2.76126526 |
| 122 | amino sugar catabolic process (GO:0046348) | 2.76013702 |
| 123 | regulation of viral release from host cell (GO:1902186) | 2.75911886 |
| 124 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.74007450 |
| 125 | protein retention in ER lumen (GO:0006621) | 2.73909181 |
| 126 | regulation of extracellular matrix disassembly (GO:0010715) | 2.73406589 |
| 127 | actin nucleation (GO:0045010) | 2.73106427 |
| 128 | nucleotide salvage (GO:0043173) | 2.71009968 |
| 129 | nodal signaling pathway (GO:0038092) | 2.70590639 |
| 130 | modulation by symbiont of host defense response (GO:0052031) | 2.68589129 |
| 131 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.68589129 |
| 132 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.68589129 |
| 133 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.68589129 |
| 134 | modulation by symbiont of host immune response (GO:0052553) | 2.68589129 |
| 135 | positive regulation by symbiont of host defense response (GO:0052509) | 2.68589129 |
| 136 | thymic T cell selection (GO:0045061) | 2.68011763 |
| 137 | pentose metabolic process (GO:0019321) | 2.67956966 |
| 138 | positive regulation of receptor recycling (GO:0001921) | 2.66940001 |
| 139 | regulation of sister chromatid cohesion (GO:0007063) | 2.66861624 |
| 140 | immunoglobulin mediated immune response (GO:0016064) | 2.66329038 |
| 141 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.66230706 |
| 142 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.65594840 |
| 143 | regulation of mast cell degranulation (GO:0043304) | 2.65410542 |
| 144 | urea metabolic process (GO:0019627) | 2.64633346 |
| 145 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.64306173 |
| 146 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.64306173 |
| 147 | regulation of early endosome to late endosome transport (GO:2000641) | 2.63777103 |
| 148 | mitotic nuclear envelope reassembly (GO:0007084) | 2.63026123 |
| 149 | nuclear envelope reassembly (GO:0031468) | 2.63026123 |
| 150 | negative regulation of cell size (GO:0045792) | 2.60766609 |
| 151 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.59559255 |
| 152 | entry into other organism involved in symbiotic interaction (GO:0051828) | 2.58801012 |
| 153 | movement in host environment (GO:0052126) | 2.58801012 |
| 154 | entry into host cell (GO:0030260) | 2.58801012 |
| 155 | movement in environment of other organism involved in symbiotic interaction (GO:0052192) | 2.58801012 |
| 156 | entry into cell of other organism involved in symbiotic interaction (GO:0051806) | 2.58801012 |
| 157 | entry into host (GO:0044409) | 2.58801012 |
| 158 | negative regulation of interleukin-2 production (GO:0032703) | 2.58373146 |
| 159 | glucose 6-phosphate metabolic process (GO:0051156) | 2.58296242 |
| 160 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.56363437 |
| 161 | regulation of leukocyte degranulation (GO:0043300) | 2.55886896 |
| 162 | myeloid dendritic cell differentiation (GO:0043011) | 2.55633695 |
| 163 | peptide biosynthetic process (GO:0043043) | 2.53469526 |
| 164 | germinal center formation (GO:0002467) | 2.52470643 |
| 165 | positive regulation of B cell differentiation (GO:0045579) | 2.52157879 |
| 166 | activation of Rac GTPase activity (GO:0032863) | 2.52155176 |
| 167 | leukotriene biosynthetic process (GO:0019370) | 2.52147894 |
| 168 | glycolipid catabolic process (GO:0019377) | 2.50405647 |
| 169 | negative regulation of cell killing (GO:0031342) | 2.50234182 |
| 170 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.50234182 |
| 171 | UV protection (GO:0009650) | 2.47994958 |
| 172 | detection of bacterium (GO:0016045) | 2.47943109 |
| 173 | regulation of defense response to virus by virus (GO:0050690) | 2.47900813 |
| 174 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.45268854 |
| 175 | cell-cell junction maintenance (GO:0045217) | 2.44488142 |
| 176 | nitrogen cycle metabolic process (GO:0071941) | 2.43032103 |
| 177 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.42802321 |
| 178 | positive thymic T cell selection (GO:0045059) | 2.42790659 |
| 179 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.41878227 |
| 180 | macrophage activation involved in immune response (GO:0002281) | 2.41433303 |
| 181 | viral entry into host cell (GO:0046718) | 2.39373833 |
| 182 | response to type I interferon (GO:0034340) | 2.37628631 |
| 183 | cellular response to type I interferon (GO:0071357) | 2.36061660 |
| 184 | type I interferon signaling pathway (GO:0060337) | 2.36061660 |
| 185 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.36016809 |
| 186 | oligosaccharide catabolic process (GO:0009313) | 2.35893477 |
| 187 | pinocytosis (GO:0006907) | 2.35517149 |
| 188 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.34514460 |
| 189 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.34372956 |
| 190 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.34090132 |
| 191 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.32523886 |
| 192 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.32126077 |
| 193 | retrograde transport, endosome to Golgi (GO:0042147) | 2.32117158 |
| 194 | detection of other organism (GO:0098543) | 2.31985401 |
| 195 | proline biosynthetic process (GO:0006561) | 10.9897496 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.90743700 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.85027125 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.77260690 |
| 4 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.68388348 |
| 5 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.68388348 |
| 6 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.68388348 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.60991237 |
| 8 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.55522753 |
| 9 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.53252121 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.49201758 |
| 11 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.41028919 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.28130221 |
| 13 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.25980382 |
| 14 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.23297522 |
| 15 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.18323084 |
| 16 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.16463718 |
| 17 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.11682173 |
| 18 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.11470108 |
| 19 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 2.10044411 |
| 20 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.07079722 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.02942581 |
| 22 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.99930216 |
| 23 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.97822371 |
| 24 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.96868652 |
| 25 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.96056488 |
| 26 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.90802257 |
| 27 | * P68_20966046_ChIP-Seq_HELA_Human | 1.89942378 |
| 28 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.89492727 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.86574778 |
| 30 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.85723713 |
| 31 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.84141188 |
| 32 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.83327981 |
| 33 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.83145484 |
| 34 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.82232748 |
| 35 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.79763837 |
| 36 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.79248714 |
| 37 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.78992042 |
| 38 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.78643469 |
| 39 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.73115503 |
| 40 | MAF_26560356_Chip-Seq_TH1_Human | 1.72770711 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72293052 |
| 42 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.71404386 |
| 43 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.71229115 |
| 44 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.67584156 |
| 45 | MAF_26560356_Chip-Seq_TH2_Human | 1.67326255 |
| 46 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.64896936 |
| 47 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.64851961 |
| 48 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.63710309 |
| 49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.63640723 |
| 50 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.63513129 |
| 51 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.57231099 |
| 52 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.57168536 |
| 53 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.55774203 |
| 54 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.55669807 |
| 55 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.54715014 |
| 56 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.54627492 |
| 57 | UTX_26944678_Chip-Seq_JUKART_Human | 1.53977360 |
| 58 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.53788331 |
| 59 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.53509331 |
| 60 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.51179491 |
| 61 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.51122736 |
| 62 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.49837538 |
| 63 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.49766584 |
| 64 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.48528762 |
| 65 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.47622111 |
| 66 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.46306412 |
| 67 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.45504204 |
| 68 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.43991219 |
| 69 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.42932921 |
| 70 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.42786422 |
| 71 | MYC_22102868_ChIP-Seq_BL_Human | 1.42293176 |
| 72 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.42238646 |
| 73 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.41966335 |
| 74 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.41408914 |
| 75 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.39141968 |
| 76 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.38680560 |
| 77 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.38134623 |
| 78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37687988 |
| 79 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.37685749 |
| 80 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.37009247 |
| 81 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.35618597 |
| 82 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.35583898 |
| 83 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.35273421 |
| 84 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.34965430 |
| 85 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.34458345 |
| 86 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.34273212 |
| 87 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.33962514 |
| 88 | KDM2B_26808549_Chip-Seq_K562_Human | 1.33531650 |
| 89 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.32867929 |
| 90 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.32302006 |
| 91 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32257982 |
| 92 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31982509 |
| 93 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.31294809 |
| 94 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.31189011 |
| 95 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.30351609 |
| 96 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.29337706 |
| 97 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.28829001 |
| 98 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.28622266 |
| 99 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.28545468 |
| 100 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.26915108 |
| 101 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.25543265 |
| 102 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.24059490 |
| 103 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.24005063 |
| 104 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22747292 |
| 105 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.22538168 |
| 106 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.21485013 |
| 107 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.21469389 |
| 108 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.20996759 |
| 109 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.20987457 |
| 110 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.20980271 |
| 111 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.20760005 |
| 112 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.20626241 |
| 113 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.20352226 |
| 114 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.20325491 |
| 115 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19973192 |
| 116 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.19847756 |
| 117 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.19713219 |
| 118 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.19700525 |
| 119 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19662789 |
| 120 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.19542349 |
| 121 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.19381522 |
| 122 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.19358053 |
| 123 | ATF3_27146783_Chip-Seq_COLON_Human | 1.19179306 |
| 124 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.17329277 |
| 125 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.17261973 |
| 126 | SA1_27219007_Chip-Seq_Bcells_Human | 1.17217371 |
| 127 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.17048809 |
| 128 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16990869 |
| 129 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16002215 |
| 130 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15432433 |
| 131 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.15146092 |
| 132 | SPI1_23127762_ChIP-Seq_K562_Human | 1.14449834 |
| 133 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.14056324 |
| 134 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.13359553 |
| 135 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.12839930 |
| 136 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.12413000 |
| 137 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.12319306 |
| 138 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12028896 |
| 139 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11692243 |
| 140 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11055244 |
| 141 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.10682516 |
| 142 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.10646536 |
| 143 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.09850168 |
| 144 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.09669848 |
| 145 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.09667003 |
| 146 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.09398990 |
| 147 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09068593 |
| 148 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08336984 |
| 149 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07019195 |
| 150 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 1.06614762 |
| 151 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06002890 |
| 152 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.05725984 |
| 153 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.05720408 |
| 154 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.05699268 |
| 155 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05615891 |
| 156 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.05461131 |
| 157 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.05113284 |
| 158 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.04869943 |
| 159 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.04215387 |
| 160 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04143167 |
| 161 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.03834781 |
| 162 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.03712015 |
| 163 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.03285059 |
| 164 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.01080591 |
| 165 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.00964114 |
| 166 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.00443144 |
| 167 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.00382940 |
| 168 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.99928871 |
| 169 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.99277964 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 5.32575782 |
| 2 | MP0009278_abnormal_bone_marrow | 3.67310579 |
| 3 | MP0010030_abnormal_orbit_morphology | 3.49751687 |
| 4 | MP0005451_abnormal_body_composition | 3.19030591 |
| 5 | MP0005171_absent_coat_pigmentation | 3.16871488 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.14017675 |
| 7 | MP0005365_abnormal_bile_salt | 3.08248504 |
| 8 | MP0002009_preneoplasia | 3.07861412 |
| 9 | MP0003436_decreased_susceptibility_to | 3.07062792 |
| 10 | MP0009840_abnormal_foam_cell | 2.96914977 |
| 11 | MP0008260_abnormal_autophagy | 2.61541211 |
| 12 | MP0004233_abnormal_muscle_weight | 2.54884343 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.53797310 |
| 14 | MP0005257_abnormal_intraocular_pressure | 2.51059797 |
| 15 | MP0003283_abnormal_digestive_organ | 2.45653347 |
| 16 | MP0008995_early_reproductive_senescence | 2.38792801 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.36678829 |
| 18 | MP0003303_peritoneal_inflammation | 2.29795776 |
| 19 | MP0010094_abnormal_chromosome_stability | 2.21430531 |
| 20 | MP0003183_abnormal_peptide_metabolism | 2.11582313 |
| 21 | MP0005397_hematopoietic_system_phenotyp | 2.04397965 |
| 22 | MP0001545_abnormal_hematopoietic_system | 2.04397965 |
| 23 | MP0003890_abnormal_embryonic-extraembry | 2.04279228 |
| 24 | MP0004947_skin_inflammation | 2.03668692 |
| 25 | MP0010234_abnormal_vibrissa_follicle | 2.00627629 |
| 26 | MP0004957_abnormal_blastocyst_morpholog | 1.98066658 |
| 27 | MP0003806_abnormal_nucleotide_metabolis | 1.97178290 |
| 28 | MP0004264_abnormal_extraembryonic_tissu | 1.96938644 |
| 29 | MP0005174_abnormal_tail_pigmentation | 1.91356279 |
| 30 | MP0005360_urolithiasis | 1.89835906 |
| 31 | MP0008058_abnormal_DNA_repair | 1.89778509 |
| 32 | MP0002139_abnormal_hepatobiliary_system | 1.89752771 |
| 33 | MP0005025_abnormal_response_to | 1.86031447 |
| 34 | MP0003786_premature_aging | 1.85933475 |
| 35 | MP0005075_abnormal_melanosome_morpholog | 1.83317553 |
| 36 | MP0004133_heterotaxia | 1.82595008 |
| 37 | MP0002419_abnormal_innate_immunity | 1.80154678 |
| 38 | MP0010352_gastrointestinal_tract_polyps | 1.77225181 |
| 39 | MP0000858_altered_metastatic_potential | 1.76749872 |
| 40 | MP0005000_abnormal_immune_tolerance | 1.75906899 |
| 41 | MP0009785_altered_susceptibility_to | 1.75685125 |
| 42 | MP0000490_abnormal_crypts_of | 1.69586357 |
| 43 | MP0002249_abnormal_larynx_morphology | 1.67341613 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.63895758 |
| 45 | MP0003119_abnormal_digestive_system | 1.62894362 |
| 46 | MP0002653_abnormal_ependyma_morphology | 1.62336057 |
| 47 | MP0001835_abnormal_antigen_presentation | 1.59934841 |
| 48 | MP0003453_abnormal_keratinocyte_physiol | 1.57571769 |
| 49 | MP0001800_abnormal_humoral_immune | 1.52405599 |
| 50 | MP0003111_abnormal_nucleus_morphology | 1.50347350 |
| 51 | MP0000462_abnormal_digestive_system | 1.48869800 |
| 52 | MP0004019_abnormal_vitamin_homeostasis | 1.48163004 |
| 53 | MP0002723_abnormal_immune_serum | 1.47123557 |
| 54 | MP0002452_abnormal_antigen_presenting | 1.46366744 |
| 55 | MP0004510_myositis | 1.45674491 |
| 56 | MP0006072_abnormal_retinal_apoptosis | 1.43071272 |
| 57 | MP0002796_impaired_skin_barrier | 1.42682340 |
| 58 | MP0002933_joint_inflammation | 1.41422516 |
| 59 | MP0002420_abnormal_adaptive_immunity | 1.41247616 |
| 60 | MP0001819_abnormal_immune_cell | 1.41159907 |
| 61 | MP0002086_abnormal_extraembryonic_tissu | 1.39491919 |
| 62 | MP0000470_abnormal_stomach_morphology | 1.36857741 |
| 63 | MP0005464_abnormal_platelet_physiology | 1.36092792 |
| 64 | MP0001348_abnormal_lacrimal_gland | 1.35771097 |
| 65 | MP0008877_abnormal_DNA_methylation | 1.35021575 |
| 66 | MP0005058_abnormal_lysosome_morphology | 1.34859291 |
| 67 | MP0001533_abnormal_skeleton_physiology | 1.34640198 |
| 68 | MP0000371_diluted_coat_color | 1.34366950 |
| 69 | MP0001790_abnormal_immune_system | 1.33991510 |
| 70 | MP0005387_immune_system_phenotype | 1.33991510 |
| 71 | MP0000604_amyloidosis | 1.33525537 |
| 72 | MP0008875_abnormal_xenobiotic_pharmacok | 1.31524221 |
| 73 | MP0005671_abnormal_response_to | 1.31121551 |
| 74 | MP0003300_gastrointestinal_ulcer | 1.31032444 |
| 75 | MP0000639_abnormal_adrenal_gland | 1.30676457 |
| 76 | MP0003693_abnormal_embryo_hatching | 1.30106262 |
| 77 | MP0000579_abnormal_nail_morphology | 1.29831051 |
| 78 | MP0003718_maternal_effect | 1.29378793 |
| 79 | MP0001845_abnormal_inflammatory_respons | 1.29131075 |
| 80 | MP0002282_abnormal_trachea_morphology | 1.27954897 |
| 81 | MP0003329_amyloid_beta_deposits | 1.27915869 |
| 82 | MP0005310_abnormal_salivary_gland | 1.26877831 |
| 83 | MP0005409_darkened_coat_color | 1.26340530 |
| 84 | MP0005076_abnormal_cell_differentiation | 1.25015683 |
| 85 | MP0001849_ear_inflammation | 1.24217579 |
| 86 | MP0001293_anophthalmia | 1.24191895 |
| 87 | MP0003763_abnormal_thymus_physiology | 1.22966985 |
| 88 | MP0008932_abnormal_embryonic_tissue | 1.22822971 |
| 89 | MP0003172_abnormal_lysosome_physiology | 1.21218692 |
| 90 | MP0008469_abnormal_protein_level | 1.18656324 |
| 91 | MP0003656_abnormal_erythrocyte_physiolo | 1.15361088 |
| 92 | MP0000716_abnormal_immune_system | 1.15084532 |
| 93 | MP0001853_heart_inflammation | 1.14436994 |
| 94 | MP0001697_abnormal_embryo_size | 1.14193183 |
| 95 | MP0001663_abnormal_digestive_system | 1.13507424 |
| 96 | MP0002084_abnormal_developmental_patter | 1.12340609 |
| 97 | MP0000678_abnormal_parathyroid_gland | 1.12168831 |
| 98 | MP0001666_abnormal_nutrient_absorption | 1.11936701 |
| 99 | MP0003077_abnormal_cell_cycle | 1.11691191 |
| 100 | MP0003567_abnormal_fetal_cardiomyocyte | 1.11130634 |
| 101 | MP0002254_reproductive_system_inflammat | 1.10542181 |
| 102 | MP0004197_abnormal_fetal_growth/weight/ | 1.09701576 |
| 103 | MP0000685_abnormal_immune_system | 1.09332484 |
| 104 | MP0003252_abnormal_bile_duct | 1.08591763 |
| 105 | MP0002998_abnormal_bone_remodeling | 1.08467146 |
| 106 | MP0002166_altered_tumor_susceptibility | 1.07962914 |
| 107 | MP0005501_abnormal_skin_physiology | 1.07810805 |
| 108 | MP0002085_abnormal_embryonic_tissue | 1.06324866 |
| 109 | MP0000015_abnormal_ear_pigmentation | 1.04274243 |
| 110 | MP0002111_abnormal_tail_morphology | 1.04019838 |
| 111 | MP0002398_abnormal_bone_marrow | 1.03882464 |
| 112 | MP0002019_abnormal_tumor_incidence | 1.02667693 |
| 113 | MP0004185_abnormal_adipocyte_glucose | 1.01405581 |
| 114 | MP0002429_abnormal_blood_cell | 1.00210490 |
| 115 | MP0003279_aneurysm | 1.00072572 |
| 116 | MP0005666_abnormal_adipose_tissue | 0.99808401 |
| 117 | MP0005266_abnormal_metabolism | 0.99398253 |
| 118 | MP0002269_muscular_atrophy | 0.98526584 |
| 119 | MP0005380_embryogenesis_phenotype | 0.97747988 |
| 120 | MP0001672_abnormal_embryogenesis/_devel | 0.97747988 |
| 121 | MP0003724_increased_susceptibility_to | 0.97435623 |
| 122 | MP0001764_abnormal_homeostasis | 0.96358515 |
| 123 | MP0001216_abnormal_epidermal_layer | 0.95720607 |
| 124 | MP0002089_abnormal_postnatal_growth/wei | 0.95456614 |
| 125 | MP0010155_abnormal_intestine_physiology | 0.95390391 |
| 126 | MP0002722_abnormal_immune_system | 0.95064388 |
| 127 | MP0003566_abnormal_cell_adhesion | 0.94810466 |
| 128 | MP0005023_abnormal_wound_healing | 0.93940022 |
| 129 | MP0005166_decreased_susceptibility_to | 0.93691095 |
| 130 | MP0009931_abnormal_skin_appearance | 0.92390833 |
| 131 | MP0000609_abnormal_liver_physiology | 0.92074339 |
| 132 | MP0000477_abnormal_intestine_morphology | 0.92050998 |
| 133 | MP0005375_adipose_tissue_phenotype | 0.91065323 |
| 134 | MP0000003_abnormal_adipose_tissue | 0.89882098 |
| 135 | MP0002060_abnormal_skin_morphology | 0.89474581 |
| 136 | MP0000689_abnormal_spleen_morphology | 0.89330084 |
| 137 | MP0005381_digestive/alimentary_phenotyp | 0.87936082 |
| 138 | MP0001873_stomach_inflammation | 0.87184404 |
| 139 | MP0002132_abnormal_respiratory_system | 0.87015688 |
| 140 | MP0000350_abnormal_cell_proliferation | 0.86178021 |
| 141 | MP0001324_abnormal_eye_pigmentation | 0.84733891 |
| 142 | MP0003866_abnormal_defecation | 0.84458677 |
| 143 | MP0000343_altered_response_to | 0.84101085 |
| 144 | MP0004858_abnormal_nervous_system | 0.83754634 |
| 145 | MP0002006_tumorigenesis | 0.81915565 |
| 146 | MP0009643_abnormal_urine_homeostasis | 0.81239527 |
| 147 | MP0005390_skeleton_phenotype | 0.80787775 |
| 148 | MP0009333_abnormal_splenocyte_physiolog | 0.80695885 |
| 149 | MP0005319_abnormal_enzyme/_coenzyme | 0.80659728 |
| 150 | MP0003075_altered_response_to | 0.80462743 |
| 151 | MP0002932_abnormal_joint_morphology | 0.79917120 |
| 152 | MP0002080_prenatal_lethality | 0.79827994 |
| 153 | MP0005220_abnormal_exocrine_pancreas | 0.79602816 |
| 154 | MP0001340_abnormal_eyelid_morphology | 0.79066353 |
| 155 | MP0005330_cardiomyopathy | 0.78086106 |
| 156 | MP0000762_abnormal_tongue_morphology | 0.78005648 |
| 157 | MP0005083_abnormal_biliary_tract | 0.77560935 |
| 158 | MP0001730_embryonic_growth_arrest | 0.77076109 |
| 159 | MP0003828_pulmonary_edema | 0.76351410 |
| 160 | MP0000467_abnormal_esophagus_morphology | 0.76246214 |
| 161 | MP0009053_abnormal_anal_canal | 0.76034627 |
| 162 | MP0005332_abnormal_amino_acid | 0.75528915 |
| 163 | MP0006082_CNS_inflammation | 0.75254397 |
| 164 | MP0002396_abnormal_hematopoietic_system | 0.74983449 |
| 165 | MP0005647_abnormal_sex_gland | 0.74551078 |
| 166 | MP0000751_myopathy | 0.74536457 |
| 167 | MP0001243_abnormal_dermal_layer | 0.74474729 |
| 168 | MP0002075_abnormal_coat/hair_pigmentati | 0.74329109 |
| 169 | MP0002405_respiratory_system_inflammati | 0.74261746 |
| 170 | MP0009384_cardiac_valve_regurgitation | 0.74108737 |
| 171 | MP0004381_abnormal_hair_follicle | 0.73362261 |
| 172 | MP0003984_embryonic_growth_retardation | 0.73061791 |
| 173 | MP0000313_abnormal_cell_death | 0.72082569 |
| 174 | MP0009115_abnormal_fat_cell | 0.71550324 |
| 175 | MP0010329_abnormal_lipoprotein_level | 0.71067731 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pustule (HP:0200039) | 5.26827836 |
| 2 | Increased IgM level (HP:0003496) | 4.81083694 |
| 3 | Rib fusion (HP:0000902) | 4.76416786 |
| 4 | Hypochromic microcytic anemia (HP:0004840) | 4.73532061 |
| 5 | Poikiloderma (HP:0001029) | 4.58932176 |
| 6 | Concave nail (HP:0001598) | 4.49297866 |
| 7 | Alopecia of scalp (HP:0002293) | 4.46879499 |
| 8 | Rectovaginal fistula (HP:0000143) | 4.43770384 |
| 9 | Rectal fistula (HP:0100590) | 4.43770384 |
| 10 | Facial hemangioma (HP:0000329) | 4.24604152 |
| 11 | Annular pancreas (HP:0001734) | 4.18599939 |
| 12 | Vaginal fistula (HP:0004320) | 4.13358228 |
| 13 | Turricephaly (HP:0000262) | 4.03923806 |
| 14 | Intestinal fistula (HP:0100819) | 3.99969107 |
| 15 | Tongue fasciculations (HP:0001308) | 3.90415127 |
| 16 | Abnormal hemoglobin (HP:0011902) | 3.89154676 |
| 17 | Thin bony cortex (HP:0002753) | 3.79462648 |
| 18 | Ulnar bowing (HP:0003031) | 3.60727897 |
| 19 | Muscle fibrillation (HP:0010546) | 3.45207740 |
| 20 | Mucopolysacchariduria (HP:0008155) | 3.39516912 |
| 21 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.39516912 |
| 22 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 3.38307795 |
| 23 | Short humerus (HP:0005792) | 3.37181117 |
| 24 | Abnormality of male internal genitalia (HP:0000022) | 3.35270322 |
| 25 | J-shaped sella turcica (HP:0002680) | 3.33637673 |
| 26 | Aplasia/hypoplasia of the humerus (HP:0006507) | 3.29087801 |
| 27 | Intestinal atresia (HP:0011100) | 3.28560156 |
| 28 | Orthostatic hypotension (HP:0001278) | 3.27861156 |
| 29 | Vertebral hypoplasia (HP:0008417) | 3.27329493 |
| 30 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 3.27329493 |
| 31 | Stridor (HP:0010307) | 3.22434800 |
| 32 | Eczematoid dermatitis (HP:0000976) | 3.20425528 |
| 33 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.19477458 |
| 34 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.19477458 |
| 35 | Abnormality of glycolipid metabolism (HP:0010969) | 3.19477458 |
| 36 | Coronal craniosynostosis (HP:0004440) | 3.19353925 |
| 37 | Abnormality of macrophages (HP:0004311) | 3.17323208 |
| 38 | Male infertility (HP:0003251) | 3.13555382 |
| 39 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.08858193 |
| 40 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.08858193 |
| 41 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.08858193 |
| 42 | Colitis (HP:0002583) | 3.03719129 |
| 43 | Malnutrition (HP:0004395) | 3.03342271 |
| 44 | Hypobetalipoproteinemia (HP:0003563) | 2.98452906 |
| 45 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.97139640 |
| 46 | Absent radius (HP:0003974) | 2.94777830 |
| 47 | Hemorrhage of the eye (HP:0011885) | 2.92962706 |
| 48 | Squamous cell carcinoma (HP:0002860) | 2.90244784 |
| 49 | Cervical subluxation (HP:0003308) | 2.88842572 |
| 50 | Hypochromic anemia (HP:0001931) | 2.85634376 |
| 51 | Anteriorly placed anus (HP:0001545) | 2.80462914 |
| 52 | Absent thumb (HP:0009777) | 2.80363541 |
| 53 | Abnormality of the aortic arch (HP:0012303) | 2.79524251 |
| 54 | Systemic lupus erythematosus (HP:0002725) | 2.77599951 |
| 55 | Upper limb amyotrophy (HP:0009129) | 2.77116479 |
| 56 | Distal upper limb amyotrophy (HP:0007149) | 2.77116479 |
| 57 | Absent forearm bone (HP:0003953) | 2.73812853 |
| 58 | Aplasia involving forearm bones (HP:0009822) | 2.73812853 |
| 59 | Dysautonomia (HP:0002459) | 2.73305247 |
| 60 | Dysostosis multiplex (HP:0000943) | 2.72261258 |
| 61 | Increased cerebral lipofuscin (HP:0011813) | 2.70801702 |
| 62 | Premature skin wrinkling (HP:0100678) | 2.70450016 |
| 63 | Albinism (HP:0001022) | 2.66724102 |
| 64 | Alacrima (HP:0000522) | 2.66499481 |
| 65 | Bifid uvula (HP:0000193) | 2.62214370 |
| 66 | Gastrointestinal inflammation (HP:0004386) | 2.61800042 |
| 67 | Polycythemia (HP:0001901) | 2.56991092 |
| 68 | Basal cell carcinoma (HP:0002671) | 2.56202949 |
| 69 | IgA deficiency (HP:0002720) | 2.54521779 |
| 70 | Patellar aplasia (HP:0006443) | 2.49328212 |
| 71 | Selective tooth agenesis (HP:0001592) | 2.49209985 |
| 72 | Congenital hip dislocation (HP:0001374) | 2.49114088 |
| 73 | Hypokinesia (HP:0002375) | 2.48807268 |
| 74 | Growth hormone excess (HP:0000845) | 2.48500736 |
| 75 | Broad face (HP:0000283) | 2.47891641 |
| 76 | Distal lower limb muscle weakness (HP:0009053) | 2.45309470 |
| 77 | Increased serum ferritin (HP:0003281) | 2.45101857 |
| 78 | Autoimmune thrombocytopenia (HP:0001973) | 2.45007511 |
| 79 | Short chin (HP:0000331) | 2.44289527 |
| 80 | Joint stiffness (HP:0001387) | 2.44155190 |
| 81 | Hypotrichosis (HP:0001006) | 2.40679537 |
| 82 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.39452400 |
| 83 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.37373419 |
| 84 | Loss of speech (HP:0002371) | 2.37249397 |
| 85 | Broad alveolar ridges (HP:0000187) | 2.36886269 |
| 86 | Cheilitis (HP:0100825) | 2.36517158 |
| 87 | Large for gestational age (HP:0001520) | 2.35792466 |
| 88 | Aplasia of the musculature (HP:0100854) | 2.32978288 |
| 89 | Hypoplasia of the radius (HP:0002984) | 2.32352348 |
| 90 | Achilles tendon contracture (HP:0001771) | 2.31972803 |
| 91 | Lower limb hyperreflexia (HP:0002395) | 2.31761052 |
| 92 | Inflammation of the large intestine (HP:0002037) | 2.31472708 |
| 93 | Flat acetabular roof (HP:0003180) | 2.30727815 |
| 94 | Thoracic kyphosis (HP:0002942) | 2.30286270 |
| 95 | Abnormality of the thoracic spine (HP:0100711) | 2.29983190 |
| 96 | Recurrent abscess formation (HP:0002722) | 2.29809128 |
| 97 | Cerebral aneurysm (HP:0004944) | 2.29220417 |
| 98 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.28087807 |
| 99 | Amyloidosis (HP:0011034) | 2.27314584 |
| 100 | Volvulus (HP:0002580) | 2.26065387 |
| 101 | Choanal stenosis (HP:0000452) | 2.25684253 |
| 102 | Vacuolated lymphocytes (HP:0001922) | 2.25099114 |
| 103 | Hypertriglyceridemia (HP:0002155) | 2.24818837 |
| 104 | Delayed epiphyseal ossification (HP:0002663) | 2.24361322 |
| 105 | Axonal loss (HP:0003447) | 2.24325516 |
| 106 | Hypophosphatemia (HP:0002148) | 2.22410893 |
| 107 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.22352070 |
| 108 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.22352070 |
| 109 | Premature graying of hair (HP:0002216) | 2.22220184 |
| 110 | Diaphragmatic weakness (HP:0009113) | 2.22034006 |
| 111 | Muscle fiber atrophy (HP:0100295) | 2.21557303 |
| 112 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.19630505 |
| 113 | Distal lower limb amyotrophy (HP:0008944) | 2.18771809 |
| 114 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.18256919 |
| 115 | Vertebral compression fractures (HP:0002953) | 2.17946082 |
| 116 | Hamartoma (HP:0010566) | 2.17025990 |
| 117 | Increased connective tissue (HP:0009025) | 2.16113918 |
| 118 | Hand muscle atrophy (HP:0009130) | 2.15739414 |
| 119 | Bowing of the arm (HP:0006488) | 2.15298918 |
| 120 | Bowed forearm bones (HP:0003956) | 2.15298918 |
| 121 | Capillary hemangiomas (HP:0005306) | 2.14866152 |
| 122 | Recurrent bacterial skin infections (HP:0005406) | 2.13767780 |
| 123 | Abnormality of the Achilles tendon (HP:0005109) | 2.12910687 |
| 124 | Intrahepatic cholestasis (HP:0001406) | 2.12247243 |
| 125 | Bone pain (HP:0002653) | 2.12174310 |
| 126 | Redundant skin (HP:0001582) | 2.11994000 |
| 127 | Hypotelorism (HP:0000601) | 2.09298431 |
| 128 | Myocardial infarction (HP:0001658) | 2.09006843 |
| 129 | Exertional dyspnea (HP:0002875) | 2.08184312 |
| 130 | Acute lymphatic leukemia (HP:0006721) | 2.07625110 |
| 131 | Type 2 muscle fiber atrophy (HP:0003554) | 2.05682469 |
| 132 | Amelogenesis imperfecta (HP:0000705) | 2.05180977 |
| 133 | Abnormality of placental membranes (HP:0011409) | 2.04763459 |
| 134 | Amniotic constriction ring (HP:0009775) | 2.04763459 |
| 135 | Opisthotonus (HP:0002179) | 2.03568457 |
| 136 | Abnormal trabecular bone morphology (HP:0100671) | 2.00702114 |
| 137 | Cellulitis (HP:0100658) | 2.00562839 |
| 138 | Decreased lacrimation (HP:0000633) | 1.98985644 |
| 139 | Bulbar palsy (HP:0001283) | 1.98953810 |
| 140 | Petechiae (HP:0000967) | 1.97880873 |
| 141 | Easy fatigability (HP:0003388) | 1.96696577 |
| 142 | Myopathic facies (HP:0002058) | 1.96630908 |
| 143 | Progressive neurologic deterioration (HP:0002344) | 1.96588542 |
| 144 | Hypoplasia of the ulna (HP:0003022) | 1.96381451 |
| 145 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.96192842 |
| 146 | Nuclear cataract (HP:0100018) | 1.96063499 |
| 147 | Clumsiness (HP:0002312) | 1.95937904 |
| 148 | Prolonged neonatal jaundice (HP:0006579) | 1.95888319 |
| 149 | Popliteal pterygium (HP:0009756) | 1.95552213 |
| 150 | Short 5th finger (HP:0009237) | 1.93732372 |
| 151 | Mediastinal lymphadenopathy (HP:0100721) | 1.92806942 |
| 152 | Gastrointestinal dysmotility (HP:0002579) | 1.92607090 |
| 153 | Reticulocytosis (HP:0001923) | 1.91572803 |
| 154 | Elevated alkaline phosphatase (HP:0003155) | 1.91042422 |
| 155 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.89477155 |
| 156 | Increased IgE level (HP:0003212) | 1.88784749 |
| 157 | Abdominal distention (HP:0003270) | 1.88542219 |
| 158 | Chronic obstructive pulmonary disease (HP:0006510) | 1.88073619 |
| 159 | Obstructive lung disease (HP:0006536) | 1.88073619 |
| 160 | Autoimmune hemolytic anemia (HP:0001890) | 1.87017652 |
| 161 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.86576967 |
| 162 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.86117776 |
| 163 | Deep venous thrombosis (HP:0002625) | 1.85919245 |
| 164 | Generalized amyotrophy (HP:0003700) | 1.85901647 |
| 165 | Xanthomatosis (HP:0000991) | 1.85120187 |
| 166 | Purpura (HP:0000979) | 1.83090129 |
| 167 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81888183 |
| 168 | Granulocytopenia (HP:0001913) | 1.81060211 |
| 169 | Neuronal loss in central nervous system (HP:0002529) | 1.80058520 |
| 170 | Abnormality of complement system (HP:0005339) | 1.79566120 |
| 171 | Abnormality of iron homeostasis (HP:0011031) | 1.77744047 |
| 172 | Upper motor neuron abnormality (HP:0002127) | 1.77623725 |
| 173 | Deformed sella turcica (HP:0002681) | 1.76508090 |
| 174 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.76190482 |
| 175 | Recurrent fungal infections (HP:0002841) | 1.76082646 |
| 176 | Flattened epiphyses (HP:0003071) | 1.75874976 |
| 177 | Hepatosplenomegaly (HP:0001433) | 1.74360748 |
| 178 | Rough bone trabeculation (HP:0100670) | 1.74335852 |
| 179 | Disproportionate tall stature (HP:0001519) | 1.73737240 |
| 180 | Long palpebral fissure (HP:0000637) | 1.73142914 |
| 181 | Cholecystitis (HP:0001082) | 1.71986121 |
| 182 | Abnormal gallbladder physiology (HP:0012438) | 1.71986121 |
| 183 | Obstructive sleep apnea (HP:0002870) | 1.71121854 |
| 184 | Interstitial pulmonary disease (HP:0006530) | 1.70857324 |
| 185 | Gingivitis (HP:0000230) | 1.70492284 |
| 186 | Asymmetric septal hypertrophy (HP:0001670) | 1.68266698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ICK | 5.77724421 |
| 2 | MAPK15 | 5.67036060 |
| 3 | MAP3K6 | 4.59609623 |
| 4 | DDR2 | 4.57382828 |
| 5 | MAP3K11 | 3.58319187 |
| 6 | MATK | 3.15964283 |
| 7 | PINK1 | 3.04414445 |
| 8 | MAP2K3 | 3.00412156 |
| 9 | PIM2 | 2.76750543 |
| 10 | TYRO3 | 2.72390732 |
| 11 | DAPK1 | 2.46748928 |
| 12 | IRAK3 | 2.44115883 |
| 13 | FGR | 2.43865451 |
| 14 | CSK | 2.32953398 |
| 15 | YES1 | 2.26038747 |
| 16 | TESK1 | 2.22676710 |
| 17 | PRKD2 | 2.20714130 |
| 18 | TESK2 | 2.04399518 |
| 19 | SMG1 | 2.03306938 |
| 20 | DYRK1B | 2.01154514 |
| 21 | AKT3 | 2.00116375 |
| 22 | UHMK1 | 1.92243947 |
| 23 | CDK7 | 1.90059049 |
| 24 | BMX | 1.89059908 |
| 25 | PDGFRA | 1.78410862 |
| 26 | IRAK4 | 1.75311839 |
| 27 | MAP3K3 | 1.72401006 |
| 28 | TBK1 | 1.70695538 |
| 29 | PKN2 | 1.62776477 |
| 30 | ZAP70 | 1.58717450 |
| 31 | TYK2 | 1.58209587 |
| 32 | BLK | 1.55555774 |
| 33 | GRK6 | 1.52116795 |
| 34 | PIM1 | 1.50411690 |
| 35 | MAPK11 | 1.43764875 |
| 36 | RIPK4 | 1.43409177 |
| 37 | CDK6 | 1.35237789 |
| 38 | TRPM7 | 1.33439564 |
| 39 | CAMKK1 | 1.30215601 |
| 40 | RIPK1 | 1.30183214 |
| 41 | MAP3K13 | 1.29482783 |
| 42 | RPS6KC1 | 1.25026495 |
| 43 | RPS6KL1 | 1.25026495 |
| 44 | SIK3 | 1.24675472 |
| 45 | MAP3K14 | 1.23918505 |
| 46 | PTK6 | 1.21921939 |
| 47 | MAP2K6 | 1.19110356 |
| 48 | TTN | 1.17141234 |
| 49 | EPHB1 | 1.16896292 |
| 50 | SIK2 | 1.11961927 |
| 51 | RPS6KA6 | 1.10501539 |
| 52 | MAP3K10 | 1.10358430 |
| 53 | DYRK3 | 1.07577819 |
| 54 | EEF2K | 1.06935254 |
| 55 | KDR | 1.05942412 |
| 56 | GSK3A | 1.02124525 |
| 57 | CDC42BPA | 1.00837291 |
| 58 | CHEK2 | 1.00380575 |
| 59 | PDPK1 | 1.00139384 |
| 60 | LATS2 | 0.90018350 |
| 61 | MAP3K1 | 0.88959532 |
| 62 | BCKDK | 0.88871100 |
| 63 | RPS6KB2 | 0.88040377 |
| 64 | PLK1 | 0.86113994 |
| 65 | RPS6KA2 | 0.83383221 |
| 66 | TAOK2 | 0.81117025 |
| 67 | EPHA2 | 0.80158721 |
| 68 | PRKG2 | 0.79931263 |
| 69 | ARAF | 0.79623469 |
| 70 | RAF1 | 0.76841180 |
| 71 | STK38L | 0.76629775 |
| 72 | CSF1R | 0.76295469 |
| 73 | JAK3 | 0.74485176 |
| 74 | LMTK2 | 0.72662812 |
| 75 | BTK | 0.72650299 |
| 76 | PHKG1 | 0.69043389 |
| 77 | PHKG2 | 0.69043389 |
| 78 | MARK2 | 0.67648436 |
| 79 | ATR | 0.66886556 |
| 80 | MTOR | 0.65918020 |
| 81 | HIPK2 | 0.64410784 |
| 82 | FES | 0.63263119 |
| 83 | MAPK12 | 0.61271719 |
| 84 | PASK | 0.60825326 |
| 85 | ABL2 | 0.59768879 |
| 86 | RPS6KA1 | 0.59419954 |
| 87 | PRKAA1 | 0.59254518 |
| 88 | BUB1 | 0.57662194 |
| 89 | LYN | 0.57324422 |
| 90 | ERN1 | 0.55561648 |
| 91 | PDK1 | 0.53147163 |
| 92 | TNK2 | 0.51880234 |
| 93 | MAP3K8 | 0.51194126 |
| 94 | CSNK2A1 | 0.50708091 |
| 95 | IRAK2 | 0.50476168 |
| 96 | ACVR1B | 0.50125676 |
| 97 | HCK | 0.50101854 |
| 98 | RPS6KB1 | 0.48469035 |
| 99 | MET | 0.48234161 |
| 100 | NEK2 | 0.47884058 |
| 101 | SIK1 | 0.46912669 |
| 102 | FLT3 | 0.44168340 |
| 103 | ERBB3 | 0.43944213 |
| 104 | IKBKE | 0.43251559 |
| 105 | MAPKAPK3 | 0.42455223 |
| 106 | MAPK3 | 0.41990165 |
| 107 | EPHB2 | 0.41770448 |
| 108 | CDK2 | 0.41638669 |
| 109 | SYK | 0.41213543 |
| 110 | PRPF4B | 0.40797833 |
| 111 | ILK | 0.40169214 |
| 112 | STK38 | 0.39927079 |
| 113 | PDK2 | 0.38961208 |
| 114 | PRKD1 | 0.38048326 |
| 115 | CAMKK2 | 0.37888375 |
| 116 | AURKA | 0.37778122 |
| 117 | TLK1 | 0.37008457 |
| 118 | CAMK2G | 0.36719152 |
| 119 | IKBKB | 0.35879381 |
| 120 | MAPK4 | 0.35546483 |
| 121 | MAP4K1 | 0.35492193 |
| 122 | EGFR | 0.35232774 |
| 123 | AURKB | 0.34664793 |
| 124 | CSNK2A2 | 0.34138580 |
| 125 | PRKAA2 | 0.33750118 |
| 126 | MAPK1 | 0.32289061 |
| 127 | CHUK | 0.31052803 |
| 128 | DYRK2 | 0.29323274 |
| 129 | CDK4 | 0.28588115 |
| 130 | MST1R | 0.27753556 |
| 131 | TRIB3 | 0.27336137 |
| 132 | CDK8 | 0.27053123 |
| 133 | MST4 | 0.26863921 |
| 134 | MAP2K2 | 0.25454721 |
| 135 | CHEK1 | 0.24339733 |
| 136 | FGFR4 | 0.23998290 |
| 137 | MAPKAPK2 | 0.23919583 |
| 138 | PDGFRB | 0.23545032 |
| 139 | MAPK14 | 0.23442441 |
| 140 | ATM | 0.22488291 |
| 141 | TAOK3 | 0.21600924 |
| 142 | TAOK1 | 0.20791402 |
| 143 | PAK2 | 0.20437288 |
| 144 | PRKCI | 0.20383007 |
| 145 | WEE1 | 0.19600459 |
| 146 | NME2 | 0.19257004 |
| 147 | PTK2 | 0.19225025 |
| 148 | PRKCD | 0.19155505 |
| 149 | INSR | 0.19047079 |
| 150 | CSNK1G1 | 0.18746660 |
| 151 | LCK | 0.18025769 |
| 152 | PAK4 | 0.16308236 |
| 153 | CDC7 | 0.16268416 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.98149523 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 4.47029684 |
| 3 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 4.05956407 |
| 4 | Base excision repair_Homo sapiens_hsa03410 | 4.04037379 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 3.55166876 |
| 6 | Sulfur relay system_Homo sapiens_hsa04122 | 2.49716750 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.27075384 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.08833996 |
| 9 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.08237893 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.04460538 |
| 11 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.04191967 |
| 12 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 2.00450681 |
| 13 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.98214994 |
| 14 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.93400448 |
| 15 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.92761759 |
| 16 | Lysosome_Homo sapiens_hsa04142 | 1.91783288 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 1.91076016 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.85996640 |
| 19 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.84746125 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.81410444 |
| 21 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.80189991 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.79819290 |
| 23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.78788935 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.66229006 |
| 25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.65246011 |
| 26 | Spliceosome_Homo sapiens_hsa03040 | 1.58606958 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.57216206 |
| 28 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.55326076 |
| 29 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.54198064 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.51412493 |
| 31 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.51108163 |
| 32 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.51093003 |
| 33 | Ribosome_Homo sapiens_hsa03010 | 1.48866539 |
| 34 | RNA transport_Homo sapiens_hsa03013 | 1.43151892 |
| 35 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.41137896 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.39364826 |
| 37 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.37761690 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.37303842 |
| 39 | Circadian rhythm_Homo sapiens_hsa04710 | 1.37261469 |
| 40 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.35242177 |
| 41 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.34674753 |
| 42 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.34347238 |
| 43 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.29613429 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.26545043 |
| 45 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.26135521 |
| 46 | Pertussis_Homo sapiens_hsa05133 | 1.25763119 |
| 47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.23526544 |
| 48 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.21765458 |
| 49 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.20955769 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 1.19169619 |
| 51 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.17445745 |
| 52 | Lysine degradation_Homo sapiens_hsa00310 | 1.16168170 |
| 53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.14148652 |
| 54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12331860 |
| 55 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.10477661 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 1.10149653 |
| 57 | Allograft rejection_Homo sapiens_hsa05330 | 1.09846738 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.09424789 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 1.08429921 |
| 60 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.07401837 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.06899443 |
| 62 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.06822720 |
| 63 | Influenza A_Homo sapiens_hsa05164 | 1.05694915 |
| 64 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.01894434 |
| 65 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.01486127 |
| 66 | Adherens junction_Homo sapiens_hsa04520 | 1.01026755 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99641473 |
| 68 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.98871777 |
| 69 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.98360686 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.98319570 |
| 71 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.97973066 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.96416466 |
| 73 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.94669787 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.94610908 |
| 75 | Bladder cancer_Homo sapiens_hsa05219 | 0.93946667 |
| 76 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.93238084 |
| 77 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.92712184 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.92105093 |
| 79 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.89442204 |
| 80 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.89409571 |
| 81 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.89270512 |
| 82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.88748701 |
| 83 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.88508235 |
| 84 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.87214812 |
| 85 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.86799139 |
| 86 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.86022309 |
| 87 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.85503464 |
| 88 | Malaria_Homo sapiens_hsa05144 | 0.85292105 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84052303 |
| 90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.82575474 |
| 91 | Cell cycle_Homo sapiens_hsa04110 | 0.82247230 |
| 92 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.82136646 |
| 93 | Hepatitis B_Homo sapiens_hsa05161 | 0.82052191 |
| 94 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.81552802 |
| 95 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.78652782 |
| 96 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.78621212 |
| 97 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.76646098 |
| 98 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.75921753 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75464197 |
| 100 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.74768450 |
| 101 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.74389169 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.74065538 |
| 103 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73960500 |
| 104 | Proteasome_Homo sapiens_hsa03050 | 0.73908091 |
| 105 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.73899234 |
| 106 | Phagosome_Homo sapiens_hsa04145 | 0.73870278 |
| 107 | Prion diseases_Homo sapiens_hsa05020 | 0.73727139 |
| 108 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.73423494 |
| 109 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72941534 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.72274256 |
| 111 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.70738489 |
| 112 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.69997551 |
| 113 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.68767688 |
| 114 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.68101892 |
| 115 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67497905 |
| 116 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.67130024 |
| 117 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.66928576 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66839328 |
| 119 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.66264997 |
| 120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65723159 |
| 121 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65463314 |
| 122 | Shigellosis_Homo sapiens_hsa05131 | 0.63938897 |
| 123 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.63435627 |
| 124 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.62866986 |
| 125 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62091118 |
| 126 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.60854119 |
| 127 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60222576 |
| 128 | ABC transporters_Homo sapiens_hsa02010 | 0.59286527 |
| 129 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59086176 |
| 130 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.59026765 |
| 131 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.58769664 |
| 132 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57555333 |
| 133 | Measles_Homo sapiens_hsa05162 | 0.56328470 |
| 134 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.56168863 |
| 135 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.56034748 |
| 136 | Retinol metabolism_Homo sapiens_hsa00830 | 0.54435236 |
| 137 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.54197517 |
| 138 | Peroxisome_Homo sapiens_hsa04146 | 0.53606606 |
| 139 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53490359 |
| 140 | Legionellosis_Homo sapiens_hsa05134 | 0.52678045 |
| 141 | Asthma_Homo sapiens_hsa05310 | 0.52611576 |
| 142 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52263974 |
| 143 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.51407995 |
| 144 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.50827233 |
| 145 | Carbon metabolism_Homo sapiens_hsa01200 | 0.50646297 |
| 146 | Histidine metabolism_Homo sapiens_hsa00340 | 0.50643972 |
| 147 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.49789995 |
| 148 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49699709 |
| 149 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.49670905 |
| 150 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49481485 |
| 151 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48940621 |
| 152 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48704528 |
| 153 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47898182 |
| 154 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.47837338 |
| 155 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47795143 |
| 156 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.46152281 |
| 157 | RNA polymerase_Homo sapiens_hsa03020 | 0.45862287 |
| 158 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.43496969 |
| 159 | Platelet activation_Homo sapiens_hsa04611 | 0.43005123 |
| 160 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42401236 |
| 161 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42175152 |
| 162 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.40790658 |
| 163 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.40588176 |
| 164 | Amoebiasis_Homo sapiens_hsa05146 | 0.39744636 |
| 165 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38860970 |
| 166 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.38512970 |
| 167 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.38468960 |
| 168 | Thyroid cancer_Homo sapiens_hsa05216 | 0.36746523 |
| 169 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.36449679 |
| 170 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.35157781 |
| 171 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33492795 |
| 172 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.31559491 |
| 173 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.31380807 |
| 174 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.30206491 |
| 175 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.28859433 |
| 176 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.27417193 |
| 177 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.26606588 |

